InvestorsHub Logo
Followers 69
Posts 7941
Boards Moderated 0
Alias Born 01/29/2015

Re: Bunions post# 11474

Tuesday, 09/01/2020 12:52:20 AM

Tuesday, September 01, 2020 12:52:20 AM

Post# of 16729
More risk.

Take the reward.

Why risk?

P3 is no guarantee.

CEO says P2 is the biggest opportunity to increase Market cap for a biotech.

A question could be do you believe him?

Same question goes for SK?

In fairness, I've been here a longtime.

Right along with a small group of ole timers who still post here (Circa 2016).

Hell, anybody here that held Btec shares is an ole timer.

All I know is I'm long overdue for a permanent split.

Covid or no Covid my time was up after CC & IPF P2.

I'm sure I've got some posts way before Covid stating just that.

What Covid has done for my investment here is add risk and dilution by many multiples.

The upside is I will never again have a stock that stumbles across some clinical paperwork that legitimately places it in the hunt for a treatment for a global pandemic.

^That evens out the scale (-/+) for me with the belief (and statistically) at least one of the P2 clinical trials will be successful.

I retain way more shares than I should, but that's still less than the number of shares I held pre-split.

My target price may be less than others.

What I do know is a positive data readout for Chronic Cough should be worth a Market cap north of 750M USD.

I don't know what a Market cap would/should look like with a positive readout for Covid or ALI or IPF.

I'd imagine they're all worth a trip to Mars.

Maybe two trips with one of them.

To date, a 750M USD Market cap is like $5.75 a share.

In my mind ^that's the finish line.

The QUESTION is: How many donut($) do you wanna make after crossing the finish line?

Covid >>> ALI >>> CC >>> IPF



It's a dizzying thought.

Just 1 opinion,

/////AMG

Outro Photo






EQ Silver Arrow